Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 156

1.

Examining the transitions between living and dying roles at end-of-life.

Lowrie D, Ray R, Plummer D, Yau M.

Death Stud. 2018 Oct 4:1-10. doi: 10.1080/07481187.2018.1504836. [Epub ahead of print]

PMID:
30285566
2.

Genome-wide meta-analysis of 158,000 individuals of European ancestry identifies three loci associated with chronic back pain.

Suri P, Palmer MR, Tsepilov YA, Freidin MB, Boer CG, Yau MS, Evans DS, Gelemanovic A, Bartz TM, Nethander M, Arbeeva L, Karssen L, Neogi T, Campbell A, Mellstrom D, Ohlsson C, Marshall LM, Orwoll E, Uitterlinden A, Rotter JI, Lauc G, Psaty BM, Karlsson MK, Lane NE, Jarvik GP, Polasek O, Hochberg M, Jordan JM, Van Meurs JBJ, Jackson R, Nielson CM, Mitchell BD, Smith BH, Hayward C, Smith NL, Aulchenko YS, Williams FMK.

PLoS Genet. 2018 Sep 27;14(9):e1007601. doi: 10.1371/journal.pgen.1007601. eCollection 2018 Sep.

3.

Semicrystalline Block Copolymers in Rigid Confining Nanopores.

Yau MYE, Gunkel I, Hartmann-Azanza B, Akram W, Wang Y, Thurn-Albrecht T, Steinhart M.

Macromolecules. 2017 Nov 14;50(21):8637-8646. doi: 10.1021/acs.macromol.7b01567. Epub 2017 Oct 18.

4.

One drug-sensitive subunit is sufficient for a near-maximal retigabine effect in KCNQ channels.

Yau MC, Kim RY, Wang CK, Li J, Ammar T, Yang RY, Pless SA, Kurata HT.

J Gen Physiol. 2018 Oct 1;150(10):1421-1431. doi: 10.1085/jgp.201812013. Epub 2018 Aug 30.

PMID:
30166314
5.

Four drug-sensitive subunits are required for maximal effect of a voltage sensor-targeted KCNQ opener.

Wang AW, Yau MC, Wang CK, Sharmin N, Yang RY, Pless SA, Kurata HT.

J Gen Physiol. 2018 Oct 1;150(10):1432-1443. doi: 10.1085/jgp.201812014. Epub 2018 Aug 30.

PMID:
30166313
6.

Long Non-Coding RNAs in Obesity-Induced Cancer.

Yau MY, Xu L, Huang CL, Wong CM.

Noncoding RNA. 2018 Aug 28;4(3). pii: E19. doi: 10.3390/ncrna4030019. Review.

7.

Pain severity as a mediator of the association between depressive symptoms and physical performance in knee osteoarthritis.

Rathbun AM, Shardell MD, Stuart EA, Yau MS, Gallo JJ, Schuler MS, Hochberg MC.

Osteoarthritis Cartilage. 2018 Nov;26(11):1453-1460. doi: 10.1016/j.joca.2018.07.016. Epub 2018 Aug 6.

PMID:
30092262
8.

Expert consensus guidelines for the genetic diagnosis of Alport syndrome.

Savige J, Ariani F, Mari F, Bruttini M, Renieri A, Gross O, Deltas C, Flinter F, Ding J, Gale DP, Nagel M, Yau M, Shagam L, Torra R, Ars E, Hoefele J, Garosi G, Storey H.

Pediatr Nephrol. 2018 Jul 9. doi: 10.1007/s00467-018-3985-4. [Epub ahead of print] Review.

PMID:
29987460
9.

Etiology and Pathogenesis of Diabetes Mellitus in Children and Adolescents.

Yau M, Maclaren NK, Sperling M.

In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, Hershman JM, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Perreault L, Purnell J, Rebar R, Singer F, Trence DL, Vinik A, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2018 Feb 13.

10.

Alternative mRNA Splicing in the Pathogenesis of Obesity.

Wong CM, Xu L, Yau MY.

Int J Mol Sci. 2018 Feb 23;19(2). pii: E632. doi: 10.3390/ijms19020632. Review.

11.

Mobility shift of beta-dystroglycan as a marker of GMPPB gene-related muscular dystrophy.

Sarkozy A, Torelli S, Mein R, Henderson M, Phadke R, Feng L, Sewry C, Ala P, Yau M, Bertoli M, Willis T, Hammans S, Manzur A, Sframeli M, Norwood F, Rakowicz W, Radunovic A, Vaidya SS, Parton M, Walker M, Marino S, Offiah C, Farrugia ME, Mamutse G, Marini-Bettolo C, Wraige E, Beeson D, Lochmüller H, Straub V, Bushby K, Barresi R, Muntoni F.

J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):762-768. doi: 10.1136/jnnp-2017-316956. Epub 2018 Feb 3.

PMID:
29437916
12.

Pre-retirement job and the work-to-retirement occupational transition process in Australia: A review.

Eagers J, Franklin RC, Yau MK, Broome K.

Aust Occup Ther J. 2018 Aug;65(4):314-328. doi: 10.1111/1440-1630.12452. Epub 2018 Jan 24. Review.

PMID:
29363140
13.

Exploring the Contemporary Stage and Scripts for the Enactment of Dying Roles: A Narrative Review of the Literature.

Lowrie D, Ray R, Plummer D, Yau M.

Omega (Westport). 2018 Mar;76(4):328-350. doi: 10.1177/0030222817696541. Epub 2017 Mar 6. Review.

PMID:
29284312
14.

A Potent Antagonist of Protease-Activated Receptor 2 That Inhibits Multiple Signaling Functions in Human Cancer Cells.

Jiang Y, Yau MK, Lim J, Wu KC, Xu W, Suen JY, Fairlie DP.

J Pharmacol Exp Ther. 2018 Feb;364(2):246-257. doi: 10.1124/jpet.117.245027. Epub 2017 Dec 20.

PMID:
29263243
15.

Clinical, genetic, and structural basis of apparent mineralocorticoid excess due to 11β-hydroxysteroid dehydrogenase type 2 deficiency.

Yau M, Haider S, Khattab A, Ling C, Mathew M, Zaidi S, Bloch M, Patel M, Ewert S, Abdullah W, Toygar A, Mudryi V, Al Badi M, Alzubdi M, Wilson RC, Al Azkawi HS, Ozdemir HN, Abu-Amer W, Hertecant J, Razzaghy-Azar M, Funder JW, Al Senani A, Sun L, Kim SM, Yuen T, Zaidi M, New MI.

Proc Natl Acad Sci U S A. 2017 Dec 26;114(52):E11248-E11256. doi: 10.1073/pnas.1716621115. Epub 2017 Dec 11.

16.

Nephrolithiasis associated with the use of topiramate in children.

Yam KM, Yau ML, Fung EL.

Hong Kong Med J. 2017 Dec;23(6):654-5. doi: 10.12809/hkmj176908. No abstract available.

17.

Genetic Determinants of Radiographic Knee Osteoarthritis in African Americans.

Liu Y, Yau MS, Yerges-Armstrong LM, Duggan DJ, Renner JB, Hochberg MC, Mitchell BD, Jackson RD, Jordan JM.

J Rheumatol. 2017 Nov;44(11):1652-1658. doi: 10.3899/jrheum.161488. Epub 2017 Sep 15.

18.

Genome-wide association and functional studies identify a role for matrix Gla protein in osteoarthritis of the hand.

den Hollander W, Boer CG, Hart DJ, Yau MS, Ramos YFM, Metrustry S, Broer L, Deelen J, Cupples LA, Rivadeneira F, Kloppenburg M, Peters M, Spector TD, Hofman A, Slagboom PE, Nelissen RGHH, Uitterlinden AG, Felson DT, Valdes AM, Meulenbelt I, van Meurs JJB.

Ann Rheum Dis. 2017 Dec;76(12):2046-2053. doi: 10.1136/annrheumdis-2017-211214. Epub 2017 Aug 30.

19.

Exploiting a novel conformational switch to control innate immunity mediated by complement protein C3a.

Lohman RJ, Hamidon JK, Reid RC, Rowley JA, Yau MK, Halili MA, Nielsen DS, Lim J, Wu KC, Loh Z, Do A, Suen JY, Iyer A, Fairlie DP.

Nat Commun. 2017 Aug 24;8(1):351. doi: 10.1038/s41467-017-00414-w.

20.

Glucuronide and Sulfate Conjugates of Bisphenol A: Chemical Synthesis and Correlation Between Their Urinary Levels and Plasma Bisphenol A Content in Voluntary Human Donors.

Ho KL, Yuen KK, Yau MS, Murphy MB, Wan Y, Fong BM, Tam S, Giesy JP, Leung KS, Lam MH.

Arch Environ Contam Toxicol. 2017 Oct;73(3):410-420. doi: 10.1007/s00244-017-0438-1. Epub 2017 Aug 2.

PMID:
28770280
21.

Congenital muscular dystrophies in the UK population: Clinical and molecular spectrum of a large cohort diagnosed over a 12-year period.

Sframeli M, Sarkozy A, Bertoli M, Astrea G, Hudson J, Scoto M, Mein R, Yau M, Phadke R, Feng L, Sewry C, Fen ANS, Longman C, McCullagh G, Straub V, Robb S, Manzur A, Bushby K, Muntoni F.

Neuromuscul Disord. 2017 Sep;27(9):793-803. doi: 10.1016/j.nmd.2017.06.008. Epub 2017 Jun 16.

PMID:
28688748
22.

Dynamic Effects of Depressive Symptoms on Osteoarthritis Knee Pain.

Rathbun AM, Stuart EA, Shardell M, Yau MS, Baumgarten M, Hochberg MC.

Arthritis Care Res (Hoboken). 2018 Jan;70(1):80-88. doi: 10.1002/acr.23239. Epub 2017 Dec 6.

23.

Biased Signaling by Agonists of Protease Activated Receptor 2.

Jiang Y, Yau MK, Kok WM, Lim J, Wu KC, Liu L, Hill TA, Suen JY, Fairlie DP.

ACS Chem Biol. 2017 May 19;12(5):1217-1226. doi: 10.1021/acschembio.6b01088. Epub 2017 Mar 14.

PMID:
28169521
24.

PAR2 Modulators Derived from GB88.

Yau MK, Liu L, Suen JY, Lim J, Lohman RJ, Jiang Y, Cotterell AJ, Barry GD, Mak JY, Vesey DA, Reid RC, Fairlie DP.

ACS Med Chem Lett. 2016 Oct 10;7(12):1179-1184. eCollection 2016 Dec 8.

25.

Mapping transmembrane residues of proteinase activated receptor 2 (PAR2) that influence ligand-modulated calcium signaling.

Suen JY, Adams MN, Lim J, Madala PK, Xu W, Cotterell AJ, He Y, Yau MK, Hooper JD, Fairlie DP.

Pharmacol Res. 2017 Mar;117:328-342. doi: 10.1016/j.phrs.2016.12.020. Epub 2016 Dec 16.

PMID:
27993717
26.

Profiling of Selected Functional Metabolites in the Central Nervous System of Marine Medaka (Oryzias melastigma) for Environmental Neurotoxicological Assessments.

Lei EN, Yau MS, Yeung CC, Murphy MB, Wong KL, Lam MH.

Arch Environ Contam Toxicol. 2017 Feb;72(2):269-280. doi: 10.1007/s00244-016-0342-0. Epub 2016 Dec 18.

PMID:
27990605
27.

Depressive symptoms and structural disease progression in knee osteoarthritis: data from the Osteoarthritis Initiative.

Rathbun AM, Yau MS, Shardell M, Stuart EA, Hochberg MC.

Clin Rheumatol. 2017 Jan;36(1):155-163. doi: 10.1007/s10067-016-3495-3. Epub 2016 Dec 12.

28.

Sulfamethazine degradation in water by the VUV/UV process: Kinetics, mechanism and antibacterial activity determination based on a mini-fluidic VUV/UV photoreaction system.

Li M, Wang C, Yau M, Bolton JR, Qiang Z.

Water Res. 2017 Jan 1;108:348-355. doi: 10.1016/j.watres.2016.11.018. Epub 2016 Nov 4.

PMID:
27847148
29.

Glucuronide and sulfate conjugates of tetrabromobisphenol A (TBBPA): Chemical synthesis and correlation between their urinary levels and plasma TBBPA content in voluntary human donors.

Ho KL, Yuen KK, Yau MS, Murphy MB, Wan Y, Fong BM, Tam S, Giesy JP, Leung KS, Lam MH.

Environ Int. 2017 Jan;98:46-53. doi: 10.1016/j.envint.2016.09.018. Epub 2016 Oct 4.

PMID:
27717582
30.

Novel Genetic Variants for Cartilage Thickness and Hip Osteoarthritis.

Castaño-Betancourt MC, Evans DS, Ramos YF, Boer CG, Metrustry S, Liu Y, den Hollander W, van Rooij J, Kraus VB, Yau MS, Mitchell BD, Muir K, Hofman A, Doherty M, Doherty S, Zhang W, Kraaij R, Rivadeneira F, Barrett-Connor E, Maciewicz RA, Arden N, Nelissen RG, Kloppenburg M, Jordan JM, Nevitt MC, Slagboom EP, Hart DJ, Lafeber F, Styrkarsdottir U, Zeggini E, Evangelou E, Spector TD, Uitterlinden AG, Lane NE, Meulenbelt I, Valdes AM, van Meurs JB.

PLoS Genet. 2016 Oct 4;12(10):e1006260. doi: 10.1371/journal.pgen.1006260. eCollection 2016 Oct.

31.

Genome-Wide Association Study of Radiographic Knee Osteoarthritis in North American Caucasians.

Yau MS, Yerges-Armstrong LM, Liu Y, Lewis CE, Duggan DJ, Renner JB, Torner J, Felson DT, McCulloch CE, Kwoh CK, Nevitt MC, Hochberg MC, Mitchell BD, Jordan JM, Jackson RD.

Arthritis Rheumatol. 2017 Feb;69(2):343-351. doi: 10.1002/art.39932.

32.

A novel mutation in HSD11B2 causes apparent mineralocorticoid excess in an Omani kindred.

Yau M, Azkawi HS, Haider S, Khattab A, Badi MA, Abdullah W, Senani AA, Wilson RC, Yuen T, Zaidi M, New MI.

Ann N Y Acad Sci. 2016 Jul;1376(1):65-71. doi: 10.1111/nyas.13162. Epub 2016 Aug 15.

PMID:
27526338
33.

Heritability of Thoracic Spine Curvature and Genetic Correlations With Other Spine Traits: The Framingham Study.

Yau MS, Demissie S, Zhou Y, Anderson DE, Lorbergs AL, Kiel DP, Allaire BT, Yang L, Cupples LA, Travison TG, Bouxsein ML, Karasik D, Samelson EJ.

J Bone Miner Res. 2016 Dec;31(12):2077-2084. doi: 10.1002/jbmr.2925. Epub 2016 Sep 6.

34.

New developments in prenatal diagnosis of congenital adrenal hyperplasia.

Kazmi D, Bailey J, Yau M, Abu-Amer W, Kumar A, Low M, Yuen T.

J Steroid Biochem Mol Biol. 2017 Jan;165(Pt A):121-123. doi: 10.1016/j.jsbmb.2016.06.016. Epub 2016 Jul 1. Review.

PMID:
27378492
35.

Prenatal Diagnosis of Congenital Adrenal Hyperplasia.

Yau M, Khattab A, New MI.

Endocrinol Metab Clin North Am. 2016 Jun;45(2):267-81. doi: 10.1016/j.ecl.2016.01.001. Epub 2016 Mar 31. Review.

PMID:
27241964
36.

Congenital Adrenal Hyperplasia: Unresolved Issues.

Yau M, Khattab A, Poppas D, Ghizzoni L, New M.

Front Horm Res. 2016;46:184-95. doi: 10.1159/000443919. Epub 2016 May 17. Review.

PMID:
27211889
37.

Results of human factors testing in a novel Hemodialysis system designed for ease of patient use.

Wilcox SB, Carver M, Yau M, Sneeringer P, Prichard S, Alvarez L, Chertow GM.

Hemodial Int. 2016 Oct;20(4):643-649. doi: 10.1111/hdi.12430. Epub 2016 May 19.

PMID:
27194590
38.

A review of occupational therapy's contribution to and involvement in the work-to-retirement transition process: An Australian perspective.

Eagers J, Franklin RC, Broome K, Yau MK.

Aust Occup Ther J. 2016 Aug;63(4):277-92. doi: 10.1111/1440-1630.12300. Epub 2016 May 17. Review.

PMID:
27188410
39.

Long term outcomes in 46, XX adult patients with congenital adrenal hyperplasia reared as males.

Khattab A, Yau M, Qamar A, Gangishetti P, Barhen A, Al-Malki S, Mistry H, Anthony W, Toralles MB, New MI.

J Steroid Biochem Mol Biol. 2017 Jan;165(Pt A):12-17. doi: 10.1016/j.jsbmb.2016.03.033. Epub 2016 Apr 25.

PMID:
27125449
40.

Receptor residence time trumps drug-likeness and oral bioavailability in determining efficacy of complement C5a antagonists.

Seow V, Lim J, Cotterell AJ, Yau MK, Xu W, Lohman RJ, Kok WM, Stoermer MJ, Sweet MJ, Reid RC, Suen JY, Fairlie DP.

Sci Rep. 2016 Apr 20;6:24575. doi: 10.1038/srep24575.

41.

Protease activated receptor 2 (PAR2) modulators: a patent review (2010-2015).

Yau MK, Lim J, Liu L, Fairlie DP.

Expert Opin Ther Pat. 2016;26(4):471-83. doi: 10.1517/13543776.2016.1154540. Epub 2016 Mar 3. Review.

PMID:
26936077
42.

Apparent mineralocorticoid excess and the long term treatment of genetic hypertension.

Razzaghy-Azar M, Yau M, Khattab A, New MI.

J Steroid Biochem Mol Biol. 2017 Jan;165(Pt A):145-150. doi: 10.1016/j.jsbmb.2016.02.014. Epub 2016 Feb 15.

PMID:
26892095
43.

Integration of occupation based intervention in hand injury rehabilitation: A Randomized Controlled Trial.

Che Daud AZ, Yau MK, Barnett F, Judd J, Jones RE, Muhammad Nawawi RF.

J Hand Ther. 2016 Jan-Mar;29(1):30-40. doi: 10.1016/j.jht.2015.09.004. Epub 2015 Nov 6.

PMID:
26847318
44.

21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia.

Nimkarn S, Gangishetti PK, Yau M, New MI.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019.
2002 Feb 26 [updated 2016 Feb 4].

45.

Potent Small Agonists of Protease Activated Receptor 2.

Yau MK, Suen JY, Xu W, Lim J, Liu L, Adams MN, He Y, Hooper JD, Reid RC, Fairlie DP.

ACS Med Chem Lett. 2015 Nov 30;7(1):105-10. doi: 10.1021/acsmedchemlett.5b00429. eCollection 2016 Jan 14.

46.

Benzylamide antagonists of protease activated receptor 2 with anti-inflammatory activity.

Yau MK, Liu L, Lim J, Lohman RJ, Cotterell AJ, Suen JY, Vesey DA, Reid RC, Fairlie DP.

Bioorg Med Chem Lett. 2016 Feb 1;26(3):986-991. doi: 10.1016/j.bmcl.2015.12.048. Epub 2015 Dec 17.

PMID:
26725028
47.

Noninvasive Prenatal Diagnosis of Congenital Adrenal Hyperplasia.

Khattab A, Yuen T, Sun L, Yau M, Barhan A, Zaidi M, Lo YM, New MI.

Endocr Dev. 2016;30:37-41. doi: 10.1159/000439326. Epub 2015 Dec 10. Review.

PMID:
26683339
48.

Potent complement C3a receptor agonists derived from oxazole amino acids: Structure-activity relationships.

Singh R, Reed AN, Chu P, Scully CC, Yau MK, Suen JY, Durek T, Reid RC, Fairlie DP.

Bioorg Med Chem Lett. 2015 Dec 1;25(23):5604-8. doi: 10.1016/j.bmcl.2015.10.038. Epub 2015 Oct 23.

PMID:
26522948
49.

Repurposing Registered Drugs as Antagonists for Protease-Activated Receptor 2.

Xu W, Lim J, Goh CY, Suen JY, Jiang Y, Yau MK, Wu KC, Liu L, Fairlie DP.

J Chem Inf Model. 2015 Oct 26;55(10):2079-84. doi: 10.1021/acs.jcim.5b00500. Epub 2015 Oct 12.

PMID:
26445028
50.

Understanding barriers to home-based and self-care in-center hemodialysis.

Yau M, Carver M, Alvarez L, Block GA, Chertow GM.

Hemodial Int. 2016 Apr;20(2):235-41. doi: 10.1111/hdi.12357. Epub 2015 Sep 28.

PMID:
26415746

Supplemental Content

Support Center